GlaxoSmithKline PLC Stock Target Price and Analyst Consensus
| GSK Stock | USD 40.50 0.16 0.39% |
The current analyst and expert consensus on GlaxoSmithKline PLC is Buy with 4 hold recommendations. The current projected GlaxoSmithKline PLC target price consensus is 39.63 with 8 analyst opinions. One of the most common ways GlaxoSmithKline PLC ADR analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to GlaxoSmithKline PLC vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on GlaxoSmithKline PLC. We strongly encourage you to use your own analysis of GlaxoSmithKline PLC ADR to validate this buy or sell advice. GlaxoSmithKline PLC recommendation module provides expert sentiment on the projected GlaxoSmithKline PLC ADR target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on GlaxoSmithKline PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 36.06 | Highest Forecast 43.99 | Target Price 39.63 |
GlaxoSmithKline |
It's important to approach GlaxoSmithKline PLC's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize GlaxoSmithKline PLC price targets
GlaxoSmithKline PLC's stock target price is an estimate of its future price, usually made by analysts. Using GlaxoSmithKline PLC's target price to determine if it is a suitable investment can be done through the following steps:- Look at GlaxoSmithKline PLC's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if GlaxoSmithKline PLC's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional GlaxoSmithKline PLC Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of GlaxoSmithKline PLC is a key component of GlaxoSmithKline PLC valuation and have some predictive power on the future returns of a GlaxoSmithKline PLC.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested one share | |
Check out Macroaxis Advice on GlaxoSmithKline PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
The data published in GlaxoSmithKline PLC's official financial statements usually reflect GlaxoSmithKline PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of GlaxoSmithKline PLC ADR. For example, before you start analyzing numbers published by GlaxoSmithKline accountants, it's critical to develop an understanding of what GlaxoSmithKline PLC's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of GlaxoSmithKline PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GlaxoSmithKline PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in GlaxoSmithKline PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GlaxoSmithKline PLC ADR. Please utilize our Beneish M Score to check the likelihood of GlaxoSmithKline PLC's management manipulating its earnings.